NURS FPX 4055 Assessment 4 Health Promotion Plan Presentation

Student Name

Capella University

NURS-FPX4055 Optimizing Population Health through Community Practice

Prof. Name

Date

Health Promotion Plan Presentation

The HPV prevention session commenced with a warm welcome, highlighting the importance of today’s gathering in Schwenksville, Pennsylvania. The target group comprises adolescents and young adults aged 11 to 26. The session focused on addressing Human Papillomavirus (HPV), its strong correlation with cancer, and the critical role of early immunization. The presentation aimed to foster informed dialogue with healthcare providers and family members. SMART goals and the Healthy People 2030 framework provided structure and guidance for this initiative.

The presentation followed a clear roadmap to ensure understanding and engagement. Key areas covered included HPV facts, its transmission routes, and how it leads to various forms of cancer. Information about the vaccine’s safety and efficacy was discussed in detail. Participants were encouraged to schedule their vaccinations within 30 days and were empowered to confidently communicate about the vaccine with both medical professionals and loved ones. Interactive elements, including group discussions and a post-session quiz, ensured the material was accessible and relevant.

HPV is one of the most prevalent viruses spread via skin-to-skin contact, often through sexual activity. Alarmingly, only 68.7% of adolescents in Pennsylvania are vaccinated, and the rates are even lower—just 48.7%—in rural areas such as Schwenksville (PA.gov, 2025). HPV is a leading cause of cervical, anal, and oropharyngeal cancers. Specifically, strains such as HPV 16 and 18 are associated with the development of cancerous cells. The virus can persist undetected for years, making proactive immunization and regular screenings essential in mitigating the associated cancer risks (Huber et al., 2021).

Timely HPV Vaccination and Communication Strategies

The HPV vaccine is most effective when administered before exposure to the virus, typically around ages 11 or 12. Administering the vaccine early strengthens the immune response, offering prolonged protection (Hoes et al., 2021). One of the most powerful benefits is the prevention of cervical cancer, which is the second most common cancer among women globally. The vaccine also prevents other cancers linked to HPV, including penile, anal, and oropharyngeal cancers (Cheng et al., 2020). Additionally, it reduces the incidence of genital warts, decreasing both physical discomfort and associated stigma.

Vaccinating a large proportion of the community also contributes to herd immunity, indirectly protecting those who cannot be vaccinated or who have compromised immune systems (Xu et al., 2024). The public health benefit extends beyond individual protection and supports broader community wellness.

To encourage uptake, individuals must be equipped to discuss HPV vaccination confidently. Effective communication strategies include providing evidence-based information, such as CDC data and peer-reviewed studies, to counter misinformation. Asking healthcare providers informed questions fosters open discussion. Addressing myths directly—like the false belief that vaccination promotes sexual activity—can help shift perceptions and emphasize the vaccine’s cancer-preventive purpose (Kassymbekova et al., 2023).

Evaluation and Alignment with Healthy People 2030

SMART goals were integrated into the session to track progress and promote outcomes. The first goal aimed for 90% of participants to correctly identify three facts about HPV and cancer, which was surpassed with a 92.5% success rate. The second goal targeted 80% commitment to scheduling the vaccine; while 75% committed, the goal was not fully achieved. The third goal—85% confidence in discussing the vaccine—was met successfully. While knowledge and confidence were high, some participants hesitated to make immediate vaccination plans, citing the need for family discussions.

To enhance effectiveness, future sessions could offer role-playing opportunities to counter misinformation and allow time for family engagement during the presentation. Follow-up sessions might help reinforce commitments and support decision-making.

In terms of alignment with Healthy People 2030, the session successfully increased awareness and empowered participants to take preventive action (U.S. Department of Health and Human Services, n.d.). Still, vaccine uptake was slightly below target, suggesting that more direct engagement with myths and hesitancies is needed. Adding real-time family discussions, evidence-driven safety talks, and consistent follow-up could help close this gap and improve adherence to national vaccination goals.

Summary Table of Key Points

References

Cheng, L., Wang, Y., & Du, J. (2020). Human papillomavirus vaccines: An updated review. Vaccines, 8(3), 391. https://doi.org/10.3390/vaccines8030391

Hoes, J., Pasmans, H., Schurink-van ’t Klooster, T. M., van der Klis, F. R. M., Donken, R., Berkhof, J., & de Melker, H. E. (2021). Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge. Human Vaccines & Immunotherapeutics, 18(1). https://doi.org/10.1080/21645515.2021.1908059

Huber, J., Mueller, A., Sailer, M., & Regidor, P.-A. (2021). Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite. Women’s Health, 17, 174550652110207. https://doi.org/10.1177/17455065211020702

Kassymbekova, F., Zhetpisbayeva, I., Tcoy, E., Dyussenov, R., Davletov, K., Rommel, A., & Glushkova, N. (2023). Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: A mixed-methods study protocol. BMJ Open, 13(9), e074097. https://doi.org/10.1136/bmjopen-2023-074097

NURS FPX 4055 Assessment 4 Health Promotion Plan Presentation

PA.gov. (2025). Dear VFC provider. https://www.pa.gov/content/dam/copapwp-pagov/en/health/documents/topics/documents/programs/immunizations/3.3.25%20-%202025%20HPV%20Call-to-Action%20Letter%20and%20Resources.pdf

U.S. Department of Health and Human Services. (n.d.). Vaccination – Healthy People 2030. Health.gov. https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination

Xu, M., Choi, J., Capasso, A., & DiClemente, R. (2024). Improving HPV vaccination uptake among adolescents in low-resource settings: Sociocultural and socioeconomic barriers and facilitators. Adolescent Health Medicine and Therapeutics, 15, 73–82. https://doi.org/10.2147/ahmt.s394119